Archives
-
Preclinical Characterization of Anlotinib: Selective VEGFR2
2026-08-03
This article examines the preclinical study of anlotinib hydrochloride, a highly selective VEGFR2 inhibitor, highlighting its anti-angiogenic mechanisms and superior efficacy over existing tyrosine kinase inhibitors. The findings have significant implications for cancer research, particularly for designing assays to interrogate endothelial cell migration and angiogenesis.
-
Scenario-Driven Reliability with Pexmetinib (ARRY-614) in Cy
2026-08-03
This article offers a scenario-based guide for bench scientists seeking reproducibility, sensitivity, and workflow confidence with Pexmetinib (ARRY-614) (SKU B6012) in inflammation and signaling pathway research. Real-world Q&A blocks illustrate how APExBIO’s dual inhibitor supports cytokine synthesis inhibition and myelodysplastic syndromes workflows, grounded in quantitative and structural evidence.
-
8-Chloroadenosine: Precision Tool for RNA Metabolism Studies
2026-08-02
8-Chloroadenosine stands out as a high-purity nucleoside analog, empowering researchers to inhibit RNA synthesis with unmatched specificity. By enabling robust transcriptional regulation workflows and precise RNA decay assays, it accelerates molecular biology research—especially in cancer and lncRNA-driven mechanisms.
-
2X HyperFusion High-Fidelity Master Mix: Precision in Clonin
2026-08-01
The 2X HyperFusion High-Fidelity Master Mix empowers researchers with ultra-accurate DNA amplification for advanced cloning and CRISPR workflows. Its unique fusion polymerase delivers unmatched fidelity and blunt-end products, transforming gene editing, immunotherapy research, and high-throughput cloning.
-
cgSHAPE-seq Maps RNA Degrader Binding Sites in SARS-CoV-2 5’
2026-07-31
The referenced study introduces chemical-guided SHAPE sequencing (cgSHAPE-seq) to pinpoint ligand binding sites within the highly structured 5’ UTR of SARS-CoV-2, enabling the rational design of RNA-degrading chimeras. This methodological advance deepens understanding of RNA-ligand interactions and supports targeted antiviral strategies.
-
Accurate Quantification of 1-methyl Adenosine in Cells by UH
2026-07-31
This article reviews a recent methodological advance for quantifying methylated purine nucleosides, including 1-methyl Adenosine, in cellular models. The study introduces a sensitive and precise stable isotope-diluted UHPLC-MS/MS platform, offering significant improvements in detection, recovery, and biomarker readiness for RNA modification research and cancer metabolism studies.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Quantitative Delivery & Tra
2026-07-30
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers researchers with dual-fluorescence, immune-evasive mRNA for precise delivery, real-time imaging, and translation efficiency assays. Its Cap 1 structure and advanced modifications enable robust, quantitative workflows for next-generation gene regulation and function studies.
-
Stable Isotope-Diluted UHPLC–MS/MS for Methylated Nucleoside
2026-07-30
This study introduces a highly sensitive, stable isotope-diluted UHPLC–MS/MS method for the precise quantification of ten methylated purine nucleosides, including 1-methyl Adenosine, in cultured cells. The approach overcomes prior analytical limitations, enabling robust metabolomic profiling and supporting advances in biomarker discovery and RNA modification research.
-
AR Heterogeneity Drives Prostate Cancer Therapy Responses
2026-07-29
This study demonstrates that androgen receptor (AR) expression heterogeneity in prostate cancer underlies distinct responses to castration and enzalutamide therapies. By integrating patient tissue analysis, engineered cell models, and xenografts, the work identifies BCL-2 as a potential therapeutic target for resistant subtypes, guiding future strategies for advanced prostate cancer.
-
L1023 Anti-Cancer Compound Library: Empowering High-Throughp
2026-07-29
The L1023 Anti-Cancer Compound Library streamlines high-throughput screening for oncology research, offering validated, pathway-focused compounds in a ready-to-use format. Its experimental flexibility and data-driven design accelerate discovery and optimize translational workflows.
-
CHIR-99021 (CT99021): Precision Modulation of Pluripotency a
2026-07-28
Explore how CHIR-99021 (CT99021) enables robust control of embryonic stem cell pluripotency and lineage commitment through targeted GSK-3 inhibition. This article reveals new mechanistic insights and practical guidance for researchers seeking to optimize differentiation protocols.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Precision in mRNA Delivery Ass
2026-07-28
ARCA Cy5 EGFP mRNA (5-moUTP) empowers quantitative, dual-fluorescence tracking of mRNA delivery and translation in mammalian cells—enabling real-time, high-clarity benchmarking of delivery systems. Optimized with 5-methoxyuridine and ARCA cap, it minimizes immune activation and boosts translational efficiency for advanced localization and efficiency assays.
-
1-methyl Adenosine: Deepening Insights into RNA Modification
2026-07-27
Explore the multifaceted role of 1-methyl Adenosine in RNA modification research, cancer metabolism studies, and biomarker discovery. This article provides an advanced analysis of epitranscriptomic mechanisms and assay innovations, offering distinct perspectives beyond current literature.
-
Adiponectin Mitigates Post-surgical Cognitive Deficits via T
2026-07-27
This study demonstrates that adiponectin treatment alleviates splenectomy-induced cognitive deficits in aged rats by suppressing neuroinflammation and oxidative stress through the TLR4/MyD88/NF-κB signaling pathway. The findings clarify mechanistic links between peripheral trauma, neuroimmune signaling, and cognitive decline, providing a translational foundation for future perioperative neuroprotection research.
-
N3-kethoxal: Precision RNA Secondary Structure Probing
2026-07-26
N3-kethoxal, or 3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one, empowers researchers to map RNA and DNA structure with high specificity, leveraging azide-mediated click chemistry for flexible labeling workflows. Its membrane-permeability and selective guanine reactivity outperform legacy probes, enabling in vivo and in vitro applications that redefine structural genomics and transcriptomics.